Contrasting Pono Capital Two (NASDAQ:PTWO) and Hims & Hers Health (NYSE:HIMS)

Pono Capital Two (NASDAQ:PTWO) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings.

Volatility & Risk

Pono Capital Two has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

Valuation & Earnings

This table compares Pono Capital Two and Hims & Hers Health’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pono Capital Two	N/A	N/A	$340,000.00	N/A	N/A
Hims & Hers Health	$872.00 million	3.25	-$23.55 million	($0.11)	-120.18

Pono Capital Two has higher earnings, but lower revenue than Hims & Hers Health.

Profitability

This table compares Pono Capital Two and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pono Capital Two	N/A	-6.63%	0.73%
Hims & Hers Health	-2.70%	-7.21%	-5.81%

Insider & Institutional Ownership

60.8% of Pono Capital Two shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 63.9% of Pono Capital Two shares are held by insiders. Comparatively, 31.6% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Pono Capital Two and Hims & Hers Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pono Capital Two	0	0	0	0	N/A
Hims & Hers Health	0	4	8	0	2.67

Hims & Hers Health has a consensus target price of $14.83, suggesting a potential upside of 12.20%. Given Hims & Hers Health’s higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Pono Capital Two.

About Pono Capital Two

Pono Capital Two, Inc. does not have any significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2022 and is based in Honolulu, Hawaii.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.